Device Trial Radar · NCT06701461
Measurement of Osteoarthritic Patient Pain Through Electrodermal Activity Signals
Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Aug 2026
Primary completion
Sep 2026
Study completion Oct 2026
Sponsor
- Lead sponsor
- Dartmouth-Hitchcock Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Connecticut
- First posted
- Nov 22, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 50 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This pilot study aims to investigate the viability of using a smartwatch-based electrodermal activity (EDA) sensor to capture enough EDA signal to quantitatively assess pain in osteoarthritis subjects and test the feasibility of its methods and procedures for later use in subsequent larger-scale studies.
Conditions
- Osteo Arthritis Knee
Interventions
Electrodermal Activity signalDevice
Determining if the electrodermal activity signals, as measured by the Embrace Plus smartwatch) can be used to measure osteoarthritic patient pain levels.
Primary outcomes
What the sponsor says the trial is designed to measure.
- :Difference in pain measurements as reported by the participant via a visual analogue scale versus smartwatch reported electrodermal activity sensorsTime frame: 40 minutes of test time, occurring all in one day.
- Patient-reported pain during standardized Osteoarthritis Research Society International (OARSI) 30-second chair testTime frame: 5 minutes
- Electrodermal activity (EDA) signals during standardized Osteoarthritis Research Society International (OARSI) 30-second chair testTime frame: 0 minutes. Concurrent with measurement of patient-reported pain.
7 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.